HSPB3 and familial pancreatic carcinoma: Similarly, overexpression of the same nonphosphorylatable HSP27 mutant with gemcitabine, a DNA replication–targeted chemotherapy treatment in pancreatic cancer cells, decreased cell proliferation (164, 167).